Shockwave Therapy for Hip Bursitis

What Is Hip Bursitis?

If you’ve been dealing with a persistent ache on the outside of your hip — one that flares when you lie on that side, climb stairs, or sit for too long — you’re likely familiar with the frustration of hip bursitis. The pain can disrupt sleep, limit exercise, and make everyday movements feel unreliable.

The condition commonly referred to as “hip bursitis” is now more accurately called greater trochanteric pain syndrome (GTPS). Clinicians have moved toward this broader term because research shows the pain often involves more than just an inflamed bursa (a fluid-filled sac that cushions the bone). In many cases, the gluteal tendons that attach near the greater trochanter (the bony prominence on the outer hip) are also degenerating or partially torn — a condition called gluteal tendinopathy.

GTPS affects an estimated 10 to 25% of the general population, with higher rates among women over 40, runners, and individuals with sedentary occupations. Traditional treatments include rest, physical therapy, anti-inflammatory medications, and corticosteroid injections. While injections can provide short-term relief, studies suggest their benefit often fades within a few months, and repeated injections may weaken tendon tissue over time.

For patients who have tried conservative measures without lasting improvement, extracorporeal shockwave therapy (ESWT) has emerged as a non-invasive alternative that aims to stimulate the body’s own healing processes rather than simply masking symptoms.

How Shockwave Therapy Works for Hip Bursitis

Extracorporeal shockwave therapy delivers focused acoustic energy waves through the skin to the affected tissue at the greater trochanter. The term “extracorporeal” simply means the energy originates outside the body — no incision or needle is required.

Two types of shockwave technology are used for GTPS:

• Focused shockwave (fESWT): Generates a precise, high-energy pulse that converges at a specific depth. This allows providers to target the exact area of tendon degeneration or bursal inflammation. Focused devices are typically used in clinical studies for hip bursitis.
• Radial shockwave (rSWT): Produces a broader, lower-energy wave that disperses from the applicator tip outward. Radial devices cover a wider treatment area and are commonly available in outpatient clinics.

The therapeutic mechanism involves several biological effects. The acoustic energy creates controlled microtrauma at the cellular level, which triggers a cascade of healing responses. These include increased local blood flow (neovascularization), release of growth factors, stimulation of collagen production, and reduction of substance P — a neurotransmitter involved in pain signaling.

In practical terms, the goal is to restart a healing process that has stalled. Chronic tendon conditions often get stuck in a cycle of failed repair, where the tissue neither fully heals nor fully breaks down. Shockwave therapy appears to disrupt that cycle and push the tissue toward active regeneration.

FDA status: Shockwave therapy is used off-label for hip bursitis. ESWT devices have FDA clearance for other musculoskeletal conditions (such as plantar fasciitis), but the specific application to GTPS has not undergone FDA review. Off-label use is a common and legal practice in medicine when supported by clinical evidence.

What the Research Says

Several clinical studies have examined shockwave therapy for greater trochanteric pain syndrome, with generally favorable results:

Rompe et al. (2009) conducted a randomized controlled trial comparing low-energy radial shockwave therapy to corticosteroid injection and home-based exercise in 229 patients with chronic GTPS. At 4-month follow-up, all three groups showed improvement. However, at the 15-month mark, the shockwave group showed significantly better outcomes — 74% of ESWT patients reported treatment success compared to 58% in the exercise group and 48% in the corticosteroid group. Notably, the corticosteroid group’s improvement declined over time, while the shockwave group’s gains held steady.

Furia et al. (2009), published in the American Journal of Sports Medicine, evaluated a single session of focused high-energy shockwave therapy in 33 patients with recalcitrant (treatment-resistant) GTPS. At 12-month follow-up, 76% of patients in the ESWT group achieved successful outcomes based on pain and functional scores, compared to 40% in the control group receiving conventional therapy. VAS (visual analog scale) pain scores dropped significantly in the shockwave group.

Del Castillo-González et al. (2016) published a prospective study in the International Journal of Surgery that followed 50 patients treated with focused ESWT for chronic GTPS. At one-year follow-up, 82% of patients reported clinically significant improvement in pain and function. The authors noted that patients with symptom duration under 12 months tended to respond better.

Ramon et al. (2015) reviewed shockwave applications across multiple tendinopathies in a systematic analysis and found consistent evidence supporting ESWT for lateral hip pain, particularly when other conservative options had been exhausted.

Carlisi et al. (2019) published a systematic review and meta-analysis in BMC Musculoskeletal Disorders that assessed the available evidence on ESWT for GTPS. The review concluded that shockwave therapy demonstrates moderate-quality evidence for pain reduction and functional improvement, with outcomes comparable to or better than corticosteroid injection at medium-term follow-up.

The evidence is encouraging but comes with important caveats. Most studies have relatively small sample sizes. There is variability in protocols — different energy levels, number of sessions, and device types — making direct comparisons difficult. More large-scale, long-term randomized trials would strengthen the evidence base.

What to Expect During Treatment

A typical shockwave therapy session for hip bursitis follows a straightforward process:

Before treatment: Your provider will review your medical history, confirm the diagnosis (sometimes using ultrasound imaging to locate the specific area of tenderness), and explain the procedure. You’ll be asked to identify your pain location and rate your current pain level.

During the session: You’ll lie on your side or in a comfortable position that exposes the lateral hip. The provider applies ultrasound gel to the skin over the greater trochanter to ensure good acoustic contact. The shockwave applicator is then pressed against the skin, and treatment begins.

Each pulse feels like a firm tap or snap against the hip. Most providers start at a lower energy setting and gradually increase intensity based on your feedback. A typical session delivers 2,000 to 3,000 pulses over approximately 10 to 15 minutes for radial devices, or 1,500 to 2,500 pulses for focused devices.

Discomfort during treatment is common but generally tolerable. On a 0-to-10 scale, most patients report discomfort in the 4 to 6 range. Providers adjust the energy level to keep the sensation manageable — the goal is therapeutic intensity without causing excessive pain.

After treatment: You can walk out of the office and resume most daily activities immediately. Your provider will likely advise you to avoid high-impact activities (running, jumping) for 24 to 48 hours after each session. Ice can be applied if the area feels sore, though some providers prefer patients avoid anti-inflammatory medications immediately after treatment, as the inflammatory response is part of the healing mechanism.

No anesthesia is required. The entire appointment, including setup and post-treatment instructions, typically takes 20 to 30 minutes.

Number of Sessions & Recovery Timeline

Most treatment protocols for hip bursitis involve 3 to 5 sessions, spaced 1 to 2 weeks apart. The specific number depends on the severity of your condition, the type of shockwave device used, and your response to initial treatments.

Here’s a general timeline of what patients experience:

• Weeks 1-2 (during treatment): Some patients notice mild pain reduction after the first session. Others may experience a temporary increase in soreness for 24 to 48 hours after each session before improvement begins.
• Weeks 3-6: Most patients begin to notice meaningful improvement in pain levels and function. The biological healing processes — new blood vessel formation, collagen remodeling — are actively underway.
• Weeks 8-12: Full therapeutic benefit typically develops during this window. Pain reduction continues to improve even after the last treatment session.
• 3-12 months: Studies show that outcomes tend to be maintained or even continue improving at longer follow-up periods, particularly when patients engage in a complementary exercise program.

Recovery from individual sessions is minimal. Most patients return to desk work and light daily activities the same day. Providers generally recommend avoiding high-impact exercise for 48 hours after each session and gradually returning to full activity as symptoms allow.

Physical therapy exercises — particularly hip abductor strengthening and gluteal activation work — are frequently prescribed alongside shockwave therapy. Research suggests that combining ESWT with targeted exercise produces better outcomes than either intervention alone.

Cost & Insurance Coverage

Shockwave therapy for hip bursitis typically costs $300 to $600 per session, with a full course of 3 to 5 sessions totaling $900 to $3,000. Prices vary based on geographic location, provider type, and whether focused or radial shockwave is used. Focused ESWT sessions tend to cost more than radial treatments.

Insurance coverage is limited for this application. Because shockwave therapy for hip bursitis is considered off-label, most private insurance plans and Medicare do not cover it. Some plans may reimburse ESWT under broader musculoskeletal treatment codes, but this varies significantly by carrier and region. Ask your provider’s office to check your specific plan before beginning treatment.

Many providers offer package pricing for the full course of treatment, which can reduce the per-session cost. Some clinics also offer payment plans or financing options. When evaluating cost, consider it relative to alternatives — repeated corticosteroid injections, ongoing physical therapy copays, or surgical intervention (which can cost $10,000 or more with associated recovery time and lost productivity).

It is reasonable to ask your provider about their success rates with ESWT for hip bursitis, the specific device they use, and whether they offer any outcome-based pricing or retreatment policies.

Who Is a Good Candidate?

Shockwave therapy for hip bursitis tends to work best for patients who meet certain criteria:

Good candidates typically include:

• Patients diagnosed with greater trochanteric pain syndrome or chronic hip bursitis lasting more than 3 months
• Individuals who have tried and not responded adequately to physical therapy, anti-inflammatory medications, or corticosteroid injections
• Patients looking for a non-invasive alternative before considering surgical options
• Active individuals (runners, athletes, fitness enthusiasts) seeking to return to activity without prolonged downtime
• Patients who have experienced only temporary relief from cortisone injections

Shockwave therapy may not be appropriate for:

• Pregnant individuals
• Patients with blood clotting disorders or those on anticoagulant medication
• Individuals with active infections or skin wounds over the treatment area
• Patients with certain implanted devices (e.g., pacemakers) near the treatment zone
• Individuals with malignancies in the treatment area
• Patients whose pain is primarily caused by a full-thickness gluteal tendon tear (surgical repair may be more appropriate)

A thorough evaluation by a qualified provider is important before starting treatment. This may include physical examination, imaging (X-ray, ultrasound, or MRI), and a review of prior treatments. Understanding the specific cause of your lateral hip pain — whether it is primarily bursitis, gluteal tendinopathy, or a combination — helps your provider determine if shockwave therapy is likely to be effective for your situation.

If you have been managing hip bursitis for months or years without lasting improvement, shockwave therapy represents a reasonable, evidence-supported option to discuss with your provider.

References

1. Rompe JD, Segal NA, Cacchio A, et al. Home training, local corticosteroid injection, or radial shock wave therapy for greater trochanter pain syndrome. Am J Sports Med. 2009;37(10):1981-1990.
2. Furia JP, Rompe JD, Maffulli N. Low-energy extracorporeal shock wave therapy as a treatment for greater trochanteric pain syndrome. Am J Sports Med. 2009;37(9):1806-1813.
3. Del Castillo-González F, Villafruela-Vicente R, Jódar-Villena A. Extracorporeal shockwave therapy for greater trochanteric pain syndrome. International Journal of Surgery. 2016;35:46-49.
4. Ramon S, Gleitz M, Giarrusso L, Maffulli N. Update on the efficacy of extracorporeal shockwave treatment of musculoskeletal diseases. Progress in Physical Rehabilitation Medicine. 2015;1(1):1-8.
5. Carlisi E, Cecini M, Moalli S, et al. Focused extracorporeal shock wave therapy for greater trochanteric pain syndrome: A systematic review and meta-analysis. BMC Musculoskelet Disord. 2019;20(1):91.